Page last updated: 2024-11-12

silidianin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID12442788
SCHEMBL ID10049341
MeSH IDM0064819

Synonyms (9)

Synonym
29782-68-1
silidianin
SCHEMBL10049341
ncgc00170023-02!
silidianine pound>>silydianin
BCP19904
(1r,3r,6r,7r,10r)-3-hydroxy-10-(4-hydroxy-3-methoxyphenyl)-8-[(2r,3r)-3,5,7-trihydroxy-4-oxo-2,3-dihydrochromen-2-yl]-4-oxatricyclo[4.3.1.0^{3,7]dec-8-en-2-one
DTXSID00865510
7a-hydroxy-8-(4-hydroxy-3-methoxyphenyl)-4-(3,5,7-trihydroxy-4-oxo-3,4-dihydro-2h-1-benzopyran-2-yl)-2,3,3a,7a-tetrahydro-3,6-methano-1-benzofuran-7(6h)-one

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" Additionally, the steady-state pharmacokinetic parameters were determined after the subjects were administered one capsule three times daily for 28 consecutive days."( An assessment of pharmacokinetics and antioxidant activity of free silymarin flavonolignans in healthy volunteers: a dose escalation study.
Bernstein, HJ; Brinda, BJ; Chavin, KD; Markowitz, JS; Patrick, KS; Zhu, HJ, 2013
)
0.39

Bioavailability

ExcerptReferenceRelevance
"In order to increase the bioavailability of mountain ginseng (MG), gold nanoparticles (MG-AuNPs) were biologically synthesized from MG extract, and an oil-in-water (O/W) nanoemulsion (SMG-AuNEs) was prepared from MG-AuNPs and a phytochemical silydianin."( Nanoemulsions prepared from mountain ginseng-mediated gold nanoparticles and silydianin increase the anti-inflammatory effects by regulating NF-κB and MAPK signaling pathways.
Kim, H; Kim, YJ; Puja, AM; Tran, THM, 2022
)
0.72
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (32)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (9.38)18.7374
1990's1 (3.13)18.2507
2000's9 (28.13)29.6817
2010's16 (50.00)24.3611
2020's3 (9.38)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (5.88%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other32 (94.12%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]